The vitamins market is estimated to be valued at USD 5.18 billion in 2018 and is projected to reach USD 7.35 billion by 2023, at a CAGR of 7.3%.
Northbrook, IL -- (SBWIRE) -- 10/11/2018 -- According to the new market research report "Vitamins Market by Type (Vitamin B, Vitamin E, Vitamin D, Vitamin C, Vitamin A, and Vitamin K), Application (Healthcare Products, Food & Beverages, Feed, and Personal Care Products), Source (Synthetic and Natural), and Region - Global Forecast to 2023", published by MarketsandMarkets™, The vitamins market is estimated to be valued at USD 5.18 billion in 2018 and is projected to reach USD 7.35 billion by 2023, at a CAGR of 7.3%. The market is driven by the growth in demand for functional and nutritionally enriched processed food products, the prevalence of vitamin deficiencies, and feed fortification due to a rise in global meat & dairy product consumption.
Don't miss out on business opportunities in Vitamins Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=159097794
The Vitamin C segment is projected to be the fastest-growing segment during the forecast period.
The vitamin C segment, by type, is projected to be the fastest-growing segment. The increasing focus of consumers on health and wellbeing, along with multiple benefits provided by vitamin C such as faster healing of wounds and maintenance of skin, eye health, and immune system provides an opportunity to this segment for increased growth.
Browse in-depth TOC on "Vitamins Market"
76 - Tables
38 - Figures
144 - Pages
View more detailed TOC @
The healthcare products segment is estimated to dominate the market in 2018.
The healthcare products segment, by application, is estimated to dominate the market during the forecast period. Rapid urbanization has led to changes in consumer lifestyles. Vitamins are gaining traction in the healthcare industry, as there is an increased focus on preventive health care. Further, vitamins are also known to sustain human health during various disorders and ailments such as diabetes, cardiovascular disease (CVD), Alzheimer's, multiple sclerosis (MS), and the common cold.
The synthetic segment is set to dominate the market by 2023.
The vitamins market, by source, is projected to be dominated by the synthetic segment, which is projected to grow at the higher rate during the forecast period. Synthetic vitamins are chemically synthesized and produced largely from coal tar derivatives and petroleum extracts. They are widely preferred by end-user industries because of their ability to remain stable for a longer period of time and also because of the low costs associated with them in comparison with naturally sourced vitamins.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=159097794
Asia Pacific is projected to be the fastest-growing market during the forecast period.
The Asia Pacific market is projected to grow at the highest CAGR from 2018 to 2023. The incidences of regular and chronic diseases in this region are high. This has led to an increased focus on preventive health care, which has resulted in high consumption of healthcare products and fortified & functional food products with essential nutrients such as vitamins. Also, the market for vitamins in Asia Pacific is experiencing high growth due to its growing application in the feed industry, as the region accounts for the largest livestock population and caters to significant demands of livestock-based products such as milk, egg, and meat.
This report includes a study of marketing and development strategies, along with a study of the product portfolios of leading companies. It includes the profiles of leading manufacturers such as Koninklijke DSM N.V. (Netherlands), Glanbia plc (Ireland), ADM (US), BASF (Germany), Lonza Group (Switzerland), Vitablend Nederland B.V. (Netherlands), SternVitamin GmbH & Co. KG (Germany), Farbest-Tallman Foods Corporation (US), Watson Inc. (US), Zagro (Singapore), The Wright Group (US), Rabar Pty Ltd. (Australia), Adisseo (France), Showa Denko K.K. (Japan), and BTSA BIOTECNOLOGíAS APLICADAS S.L (Spain).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vitamins-market.asp
Visit Our Website: https://www.marketsandmarkets.com